HUP9902457A2 - Pneumococcus felületi fehérjéket tartalmazó oltóanyag-készítmények - Google Patents

Pneumococcus felületi fehérjéket tartalmazó oltóanyag-készítmények

Info

Publication number
HUP9902457A2
HUP9902457A2 HU9902457A HUP9902457A HUP9902457A2 HU P9902457 A2 HUP9902457 A2 HU P9902457A2 HU 9902457 A HU9902457 A HU 9902457A HU P9902457 A HUP9902457 A HU P9902457A HU P9902457 A2 HUP9902457 A2 HU P9902457A2
Authority
HU
Hungary
Prior art keywords
surface proteins
pneumococcal surface
strain selection
pneumococcal
strain
Prior art date
Application number
HU9902457A
Other languages
English (en)
Inventor
Robert S. Becker
David E. Briles
Susan Hollingshead
Original Assignee
Uab Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uab Research Foundation filed Critical Uab Research Foundation
Publication of HUP9902457A2 publication Critical patent/HUP9902457A2/hu
Publication of HUP9902457A3 publication Critical patent/HUP9902457A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pulmonology (AREA)
  • Pathology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)

Abstract

A találmány tárgyát legalább két, különböző törzsekből származópneűmőcőccűs felszíni A-fehérjét (PspA-t) tartalmazó őltóanyag-készítmények képezik. A találmány szerinti megőldás alkalmaspneűmőcőccűsők átlal kiváltőtt fertőzésekkel szembeni védettségkialakítására. ŕ
HU9902457A 1996-09-20 1997-09-22 Strain selection of pneumococcal surface proteins HUP9902457A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/710,749 US5955089A (en) 1993-04-20 1996-09-20 Strain selection of pneumococcal surface proteins

Publications (2)

Publication Number Publication Date
HUP9902457A2 true HUP9902457A2 (hu) 1999-11-29
HUP9902457A3 HUP9902457A3 (en) 2000-03-28

Family

ID=24855364

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9902457A HUP9902457A3 (en) 1996-09-20 1997-09-22 Strain selection of pneumococcal surface proteins

Country Status (9)

Country Link
US (3) US5955089A (hu)
EP (1) EP0956043A4 (hu)
JP (2) JP2000503676A (hu)
AU (1) AU726927B2 (hu)
CA (1) CA2267343A1 (hu)
HU (1) HUP9902457A3 (hu)
NO (1) NO991340L (hu)
NZ (1) NZ334811A (hu)
WO (1) WO1998011915A1 (hu)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955089A (en) * 1993-04-20 1999-09-21 Uab Research Foundation Strain selection of pneumococcal surface proteins
US7078042B2 (en) * 1995-09-15 2006-07-18 Uab Research Foundation Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
US20010016200A1 (en) * 1998-04-23 2001-08-23 Briles David E. Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
CA2332173A1 (en) * 1998-06-19 1999-12-23 Government Of The Republic Of Singapore A vaccine-induced hepatitis b viral strain and uses thereof
EP1034792A1 (en) * 1999-03-11 2000-09-13 Pasteur Merieux Serums Et Vaccins Intranasal delivery of pneumococcal polysaccharide vaccines
AU2001269833A1 (en) * 2000-06-14 2001-12-24 Cytovax Biotechnologies, Inc. Use of coiled-coil structural scaffold to generate structure-specific peptides
US7272643B1 (en) * 2000-09-13 2007-09-18 Fortinet, Inc. System and method for managing and provisioning virtual routers
US7574495B1 (en) * 2000-09-13 2009-08-11 Fortinet, Inc. System and method for managing interworking communications protocols
US20040116661A1 (en) * 2000-10-26 2004-06-17 Holden David William Streptococcal genes
WO2003090726A2 (en) 2002-04-25 2003-11-06 Banner Pharmacaps, Inc. Chewable soft capsule
US7203192B2 (en) * 2002-06-04 2007-04-10 Fortinet, Inc. Network packet steering
US7376125B1 (en) * 2002-06-04 2008-05-20 Fortinet, Inc. Service processing switch
US7096383B2 (en) 2002-08-29 2006-08-22 Cosine Communications, Inc. System and method for virtual router failover in a network routing system
EP1668112A4 (en) 2003-06-20 2009-04-29 Protein Sciences Corp SARS IMMUNOGENOUS EXPRESSING VECTORS, SUCH VECTORS OR EXPRESSION PRODUCTS COMPRISING THOSE COMPOSITIONS, PROCESSES AND TESTS FOR THE PREPARATION AND USE THEREOF
US7304139B2 (en) * 2003-10-28 2007-12-04 University Of Florida Research Foundation, Inc. Polynucleotides and polypeptides of Anaplasma phagocytophilum and methods of using the same
US7499419B2 (en) * 2004-09-24 2009-03-03 Fortinet, Inc. Scalable IP-services enabled multicast forwarding with efficient resource utilization
US7808904B2 (en) * 2004-11-18 2010-10-05 Fortinet, Inc. Method and apparatus for managing subscriber profiles
WO2009103312A1 (en) * 2008-02-19 2009-08-27 Ludwig-Maximilians-Universität Ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for psoriasis and poststreptococcal diseases
ES2325243B1 (es) * 2008-02-27 2011-05-04 Universidad De Granada Antigeno recombinante.
CU23919B1 (es) * 2010-09-28 2013-07-31 Ct De Ingeniería Genética Y Biotecnología Composición vacunal para el control de las infestaciones por ectoparásitos
BR112013015009B1 (pt) * 2010-12-22 2020-11-10 Intervet International B.V vacina para proteger um animal contra uma doença clínica decorrente de uma infecção com bordetella bronchiseptica
WO2014045621A1 (ja) 2012-09-19 2014-03-27 国立大学法人大阪大学 肺炎球菌表面タンパク質ａを含む肺炎球菌ワクチン
CN104306965B (zh) * 2014-10-31 2017-05-10 康希诺生物股份公司 预防肺炎链球菌感染性疾病的免疫原性组合物及制备方法
CN110381992A (zh) 2016-12-03 2019-10-25 Uab研究基金会 组合了肺炎球菌表面蛋白A的选择的α螺旋结构域和脯氨酸富集结构域的肺炎球菌疫苗

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673574A (en) 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4496538A (en) 1982-07-06 1985-01-29 Connaught Laboratories, Inc. Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine
US5019384A (en) 1986-06-30 1991-05-28 Massachusetts Institute Of Technology Immunonodulating compositions and their use
US5679768A (en) 1991-02-15 1997-10-21 Uab Research Foundation Epitopic regions of pneumococcal surface protein A
US5476929A (en) 1991-02-15 1995-12-19 Uab Research Foundation Structural gene of pneumococcal protein
US5955089A (en) 1993-04-20 1999-09-21 Uab Research Foundation Strain selection of pneumococcal surface proteins
CA2116261A1 (en) * 1993-04-20 1994-10-21 David E. Briles Epitopic regions of pneumococcal surface protein a

Also Published As

Publication number Publication date
JP2003002842A (ja) 2003-01-08
WO1998011915A1 (en) 1998-03-26
US6638516B1 (en) 2003-10-28
CA2267343A1 (en) 1998-03-26
AU4428797A (en) 1998-04-14
AU726927B2 (en) 2000-11-23
US5955089A (en) 1999-09-21
US20040067237A1 (en) 2004-04-08
US7189404B2 (en) 2007-03-13
NZ334811A (en) 2000-09-29
EP0956043A4 (en) 2002-10-30
HUP9902457A3 (en) 2000-03-28
NO991340L (no) 1999-05-18
NO991340D0 (no) 1999-03-19
JP2000503676A (ja) 2000-03-28
EP0956043A1 (en) 1999-11-17

Similar Documents

Publication Publication Date Title
HUP9902457A2 (hu) Pneumococcus felületi fehérjéket tartalmazó oltóanyag-készítmények
BR0012243A (pt) Triflúor butenos nematocidas
NL300271I1 (nl) DNA dat humaan papillomavirus type 18 codeert.
HUP9802212A2 (hu) Humán terápiában alkalmazható rekombináns anti-CD4-ellenanyagok
BG101384A (en) New pesticide proteins and strains
ATE328068T1 (de) Papillomavirus vakzine
DE69940545D1 (de) Impfstoffe welche antiidiotypische antikörper enthalten, die kohlenhydrate von streptococcus gruppe b nachahmen
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
WO1996014314A3 (en) Thiepane compounds inhibiting and detecting hiv protease
EA200100700A1 (ru) Гены и белки и их применение
PT635025E (pt) Processo para preparar proteinas modificadas
AU626070B2 (en) Anticoagulant peptide alcohols
AU6368890A (en) Anticoagulant peptides
SE9602822D0 (sv) New receptor
ES2094228T3 (es) Peptidos anticoagulantes.
IT8820117A0 (it) Procedimento per la preparazione di bis(2,2,6,6_tetrametil_4_piperidil)ammina.
AU2190288A (en) Vector for the expression of proteins of the HIV-2 virus, one of the casual agents of AIDS, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained
EA200100701A1 (ru) Белки наружной поверхности, их гены и их применение
SE9604439D0 (sv) New receptor
FR2646607B1 (fr) Anticorps monoclonaux anti-b2 microglobuline
DK0858465T3 (da) Protein med antitumorvirkning.
FR2654430B1 (fr) Nouveaux derives de peptides, utilisables comme inhibiteurs des collagenases bacteriennes.
IT8421612A0 (it) Vettore clonante, procedimento per la sua costruzione e procedimentodi concentrazione e di purificazione di proteine prodotte, formate dal vettore clonante.
RU2076528C1 (ru) Штамм вируса омской геморрагической лихорадки для приготовления диагностических препаратов
RO103864B1 (ro) Unguent antiherpetic